Meeting
2021 ASCO Quality Care Symposium
Risk factors for ED visits and admissions during outpatient chemotherapy in head and neck cancer.
Authors
Navika Shukla
Stanford Health Care, Stanford, CA
Navika Shukla, Anirudh Saraswathula, Saad A. Khan, Vasu Divi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care
Track
Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Prospective Risk Assessment and Reduction
Citation
J Clin Oncol 39, 2021 (suppl 28; abstr 223)
DOI
10.1200/JCO.2020.39.28_suppl.223
Abstract #
223
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Outpatient versus inpatient delivery of intensive chemotherapy for patients with hematological neoplasms: A 5-year experience from a tertiary center.
First Author: Luluh Bin Dayil
Poster
2022 ASCO Annual Meeting
Reducing inpatient mortality in patients with cancer through multidisciplinary review and targeted interventions.
First Author: Manan P Shah
Poster
2021 ASCO Annual Meeting
Transitioning ifosfamide based chemotherapy to the outpatient setting: A model of implementation of transitioning chemotherapy outpatient in a safety net hospital.
First Author: Cindy Banh
Poster
2019 ASCO Quality Care Symposium
Successful creation of an outpatient team-based model for traditionally inpatient chemotherapy.
First Author: Timothy Edward Kubal